Correlation Between Diffusion Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Diffusion Pharmaceuticals and Virax Biolabs
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Diffusion and Virax is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Diffusion Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to generate 0.21 times more return on investment than Virax Biolabs. However, Diffusion Pharmaceuticals is 4.74 times less risky than Virax Biolabs. It trades about 0.62 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.03 per unit of risk. If you would invest 307.00 in Diffusion Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 20.00 from holding Diffusion Pharmaceuticals or generate 6.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
Diffusion Pharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Virax Biolabs Group |
Diffusion Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diffusion Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Diffusion Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |